Benitec Biopharma Operating Income

Benitec Biopharma (BNTC) currently reports a operating income of $-54M as of March 2026. That compares with $-30M in the prior-year period — down 79.0% year over year. Use the charts on this page to explore Benitec Biopharma's operating income history and peer comparisons.

Benitec Biopharma's operating income decreased from $-30M to $-54M — a 79.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Benitec Biopharma reported $-54M in operating income as of March 2026. That compares with $-30M in the prior-year period — down 79.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-54M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Benitec Biopharma, and consider following BNTC for alerts when major investors trade the stock.